Physical Functioning Following Total Hip Arthroplasty

This study has been completed.
Sponsor:
Information provided by:
Soroka University Medical Center
ClinicalTrials.gov Identifier:
NCT00651430
First received: January 14, 2008
Last updated: June 10, 2010
Last verified: December 2007
  Purpose

Adults suffer from Osteoarthrosis of hip joint that willing to participate in the study will be tested with well-established measuring techniques of Balance control using force plate before 3 month and 6 month after Total Knee Arthroplasty (THA) in the movement and Rehabilitation Laboratory at BGU. An automated algorithm will be used to extract standardized stabilogram-diffusion parameters from each of the COP data sets collected during quiet standing. These parameters include diffusion coefficients, critical displacement, critical time and scaling exponents for both lateral and anterior-posterior sway directions (Collins & De Luca, 1993). Each of the Times (before 3 month and 6 month after the THA) in two task conditions (eyes closed and eyes close conditions). Participants will be required to stand on the platform 10 times for 30 s For each trial, they will be instructed to sway as little as possible. In addition step execution test and Late life function and disability questionnaires will be also examined.


Condition
Osteoarthrosis, Balance Control, Voluntary Movement Control

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Step Execution, Stability, Quality of Life, Fear of Falling and Their Association Following Total Hip Arthroplasty

Further study details as provided by Soroka University Medical Center:

Primary Outcome Measures:
  • SDF parameters [ Time Frame: before, 3 month and 6 month after the THA ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Late Life Function and disability, Fall efficacy scale, step execution test [ Time Frame: before 3 month and 6 month after ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

no biospecimens are to be retained


Estimated Enrollment: 30
Study Start Date: March 2008
Study Completion Date: May 2010
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)

  Eligibility

Ages Eligible for Study:   40 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

30 adults suffer from Hip OA prior THA

Criteria

Inclusion Criteria:

  • Able to stand safely for 30 seconds
  • Able to walk independently
  • Hip OA prior THA

Exclusion Criteria:

  • Stroke or other neurological diseases
  • Minimal score 24 or higher
  • Blindness
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00651430

Locations
Israel
SorokaUMC
Beer-Sheva, Israel
Soroka Medical Center
Beer-Sheva, Israel, 84105
Sponsors and Collaborators
Soroka University Medical Center
Investigators
Study Director: Vadim Benkovich, MD Soroka Medical Center
Principal Investigator: Itshak Melzer, PhD, PT Ben-Gurion University of the Negev
  More Information

No publications provided

Responsible Party: Itshak Melzer PhD, PT, Ben-Gurion University of the Negev
ClinicalTrials.gov Identifier: NCT00651430     History of Changes
Other Study ID Numbers: sor462807ctil, MB4628
Study First Received: January 14, 2008
Last Updated: June 10, 2010
Health Authority: Israel: Ethics Commission

Keywords provided by Soroka University Medical Center:
Balance
Voluntary stepping
function
disability
fear of falls
Total Hip Arthroplasty

Additional relevant MeSH terms:
Joint Diseases
Osteoarthritis
Musculoskeletal Diseases
Arthritis
Rheumatic Diseases

ClinicalTrials.gov processed this record on April 21, 2014